# OnCo record nct07265674 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07265674/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07265674", "NCT07265674" ;
  schema:name "A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer"@en ;
  schema:alternateName "Beacon-BTC"@en ;
  schema:description "A phase 3 trial of Nanvuranlat in biliary tract cancer, run by J-Pharma Co., Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07265674/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07265674> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2026-05-11" ;
  onco:cancers <https://onco.cc/cancers/cholangiocarcinoma/> .